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The intestinal epithelium performs vital roles in organ function by absorbing nutrients and providing a
protective barrier. The zinc-ﬁnger containing transcription factors GATA4 and GATA6 regulate enterocyte
gene expression and control regional epithelial cell identity in the adult intestinal epithelium. Although
GATA4 and GATA6 are expressed in the developing intestine, loss of either factor alone during the period
of epithelial morphogenesis and cytodifferentiation fails to disrupt these processes. Therefore, we tested
the hypothesis that GATA4 and GATA6 function redundantly to control these aspects of intestinal
development. We used Villin-Cre, which deletes speciﬁcally in the intestinal epithelium during the
period of villus development and epithelial cytodifferentiation, to generate Gata4Gata6 double condi-
tional knockout embryos. Mice lacking GATA4 and GATA6 in the intestinal epithelium died within 24 h of
birth. At E18.5, intestinal villus architecture and epithelial cell populations were altered. Enterocytes
were lost, and goblet cells were increased. Proliferation was also increased in GATA4-GATA6 deﬁcient
intestinal epithelium. Although villus morphology appeared normal at E16.5, the ﬁrst time at which both
Gata4 and Gata6 were efﬁciently reduced, changes in expression of markers of enterocytes, goblet cells,
and proliferative cells were detected. Moreover, goblet cell number was increased at E16.5. Expression of
the Notch ligand Dll1 and the Notch target Olfm4 were reduced in mutant tissue indicating decreased
Notch signaling. Finally, we found that GATA4 occupies chromatin near the Dll1 transcription start site
suggesting direct regulation of Dll1 by GATA4. We demonstrate that GATA4 and GATA6 play an essential
role in maintaining proper intestinal epithelial structure and in regulating intestinal epithelial
cytodifferentiation. Our data highlight a novel role for GATA factors in ﬁne tuning Notch signaling
during intestinal epithelial development to repress goblet cell differentiation.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The intestinal epithelium plays a central role in orchestrating
organ function through nutrient absorption and by providing a
barrier between the environment and underlying tissues. During
embryonic development, epithelial morphogenesis and cytodiffer-
entiation in midgut endoderm produce a precisely structured
epithelium composed of specialized cell types that perform these
functions (Spence et al., 2011). In mouse, between embryonic day
14 (E14) and birth, the immature pseudostratiﬁed epithelium of
the gut converts to a simple columnar epithelium covering mucosal
projections known as villi (Grosse et al., 2011). Coincident with
epithelial morphogenesis, progenitor cells differentiate into absorp-
tive or secretory cell types. As the epithelium remodels, proliferative
progenitor cells become restricted to intervillus regions, which
mark the future sites of crypts where intestinal stem cells and
secretory Paneth cells will reside (Spence et al., 2011).
One family of factors implicated in enterocyte development is
the GATA family of zinc-ﬁnger DNA binding transcription factors,
speciﬁcally GATA4 and GATA6. Both GATA4 and GATA6 are
expressed in midgut endoderm during development and continue
to be expressed in the small intestinal epithelium throughout
adulthood although in differing patterns (Koutsourakis et al., 1999;
Bosse et al., 2006; Bosse et al., 2007; Watt et al., 2007; Battle et al.,
2008; Beuling et al., 2011). Epithelial cells of duodenum and
jejunum express GATA4, whereas those of the ileum lack GATA4
(Bosse et al., 2006; Battle et al., 2008). GATA6, however, is
expressed in all regions of the small intestinal epithelium (Fang
et al., 2006). Because Gata4−/− and Gata6−/− mice die during
embryogenesis prior to organ development (Kuo et al., 1997;
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Molkentin et al., 1997; Morrisey et al., 1998; Koutsourakis et al.,
1999), it was necessary to use a conditional knockout approach to
study their function in the small intestine. Using Villin-Cre, which
directs robust intestinal epithelium-speciﬁc recombination during
development beginning at the time of villus morphogenesis and
epithelial cytodifferentiation (Madison et al., 2002), we previously
eliminated GATA4 from the intestine. We found that although
GATA4 is dispensable for proper intestinal development when
deleted during the period of epithelial morphogenesis and cyto-
differentiation with Villin-Cre, it is essential for jejunal function
(Battle et al., 2008). Mice lacking GATA4 in the jejunal epithelium
displayed severe defects in fat and cholesterol absorption. More-
over, mutant jejunum lost expression of many jejunal-speciﬁc
genes and gained expression of many ileal-speciﬁc genes suggest-
ing that GATA4 plays a key role in determining jejunal enterocyte
identity. Conditional knockout of GATA4 in adult mouse small
intestine using tamoxifen-inducible Villin-Cre resulted in a similar
phenotype (Bosse et al., 2006). Loss of GATA6 from the intestinal
epithelium using Villin-Cre also fails to disrupt embryonic intest-
inal development (Battle lab, unpublished data). Conditional
knockout of Gata6 in adult mouse small intestinal epithelium
using tamoxifen-inducible Villin-Cre alters ileal epithelial cell
populations including a reduction of proliferative, enteroendo-
crine, and Paneth cells and an increase in goblet cells (Beuling
et al., 2011). Loss of Gata6 in the ileum also causes changes in the
ileal enterocyte-speciﬁc gene expression pattern, shifting it toward
a more distal colon-like pattern (Beuling et al., 2011).
The ﬁnding that GATA4 and GATA6 are expressed in the
developing intestine, yet loss of either factor alone during the
period of epithelial morphogenesis and cytodifferentiation fails to
disrupt intestinal development, suggests that these factors func-
tion redundantly during this period of small intestinal develop-
ment. Redundancy in GATA4-GATA6 function has been
demonstrated during development of other organs. For example,
loss of either GATA4 or GATA6 in the heart results in subtle
phenotypes whereas loss of both factors causes acardia (Zhao
et al., 2008). Studies examining GATA4 and GATA6 in pancreatic
development conﬁrm a similar model of GATA function. Loss of
either GATA4 or GATA6 causes minor defects, whereas elimination
of both results in pancreatic agenesis (Carrasco et al., 2012; Xuan
et al., 2012). Further supporting redundant function of GATA
factors in the small intestinal epithelium, conditional knockout
of Gata4 and Gata6 in adult mouse small intestinal epithelium
using tamoxifen-inducible Villin-Cre causes changes in the duo-
denum and jejunum similar to those seen in GATA6-deﬁcient
ileum including a reduction of proliferative, enteroendocrine, and
Paneth cells and an increase in goblet cells (Beuling et al., 2011).
The impact of loss of both GATA4 and GATA6 on intestinal
development, however, is unknown. Therefore, to test the hypoth-
esis that GATA4 and GATA6 regulate a common set of genes to
control intestinal development, Gata4Gata6 double conditional
knockout (G4G6 dcKO) mice were generated using Villin-Cre. We
found that unlike single Gata4 or Gata6 Villin-Cre cKO mice or
mice with deletion of both Gata4 and Gata6 in adult intestine,
elimination of both Gata4 and Gata6 during development resulted
in death within 24 hours of birth. Both epithelial architecture and
cell type allocation were affected in GATA4-GATA6 deﬁcient
intestine. Although villi emerged normally in mutants, villus
structure was abnormal at E18.5 with mutant tissue containing
scarce short, broad villi. We observed a decrease in enterocytes
and an increase in proliferating cells and goblet cells. Reduced
expression of the Notch ligand Dll1 (Pellegrinet et al., 2011) and
the Notch downstream target Olfm4 (VanDussen et al., 2012)
suggested defective Notch signaling, and we found that GATA4
occupied binding sites within the Dll1 gene in the intestinal
epithelium. We conclude that GATA4 and GATA6 play an essential
role in regulating intestinal epithelial structure and cytodifferen-
tiation. Moreover, the data we present suggest a role for GATA
factors in intestinal epithelial cell fate decisions by modulating
Notch signaling through regulation of Dll1.
Materials and methods
Animals
Gata4loxP(Gata4tm1.1Sad), Gata6loxP(Gata6tm2.1Sad), Gata6−(Gata6
tm2.2Sad), Villin-Cre(Tg(Vil-cre)997Gum), Gata4ﬂbio(Gata4tm3.1Wtp) and
Rosa26BirA(Gt(ROSA)26Sortm1(birA)Mejr) mice were used (Madison et al.,
2002; Watt et al., 2004; Driegen et al., 2005; Sodhi et al., 2006; He
et al., 2012). Embryonic mice were generated by timed mating
considering noon on the day of a vaginal plug as E0.5. Genotypes
were determined by PCR of tail tip or ear punch DNA following a
standard protocol. Primers are listed in Supplemental Table 1. For
proliferation studies, 200 mg 5-ethynyl-2'deoxyuridine (EdU) was
administered by intraperitoneal injection 3 h prior to euthanizing
animals. The Medical College of Wisconsin's Animal Care Committee
approved all animal procedures.
Intestinal epithelial cell isolation
Whole small intestine harvested from control and G4G6 dcKO
E16.5, E17.5, or E18.5 embryos was cut along its longitudinal axis
and incubated in cell dissociation buffer (BD Biosciences, San Jose,
CA) for 6 h at 4 1C with gentle agitation to release epithelial cells
(Madison et al., 2005; Li et al., 2007). Total RNA prepared from
epithelial cells was used for gene array and qRT-PCR analyses.
Reverse transcription polymerase chain reaction
cDNA was generated from DNase treated RNA harvested from
intestinal epithelial cells isolated from the whole small intestine
(E16.5-E18.5) or from intact jejunal tissue harvested from themidpoint
of small intestine (E15.5) as previously described (Duncan et al., 1997;
Bondow et al., 2012). Supplemental Table 1 and 2 contain primer
sequences and TaqMan assay identiﬁers, respectively. qRT-PCR data
were analyzed using DataAssist software (Applied Biosystems, Carls-
bad, CA). Gapdhwas used for normalization. Each gene was assayed in
at least three independent experiments using cDNA from three control
and three mutant intestines. Error bars represent standard error of the
mean (SEM).
Oligonucleotide array analysis
Mouse Gene 1.0 ST arrays (Affymetrix, Santa Clara, CA) were used
to determine gene expression changes between intestinal epithelial
cells harvested from three control and three G4G6 dcKO embryos at
E18.5 as previously described (Bondow et al., 2012). To be considered
signiﬁcantly changed between groups, we required an expression
change of Z2.0-fold, pr0.05 (Supplemental Table 3).
Histochemistry, Immunohistochemistry, and Immunoﬂuorescence
Histochemistry, immunohistochemistry, and immunoﬂuores-
cence were performed as previously described using jejunal tissue
harvested from the midpoint of each embryonic small intestine
(Duncan et al., 1997; Bondow et al., 2012). For each stain, four to
six sections from three controls and three mutant animals were
used. See Supplemental Table 4 for antibody details.
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Biotin-mediated chromatin immunoprecipitation (bio-ChIP)
Epithelial cells from the jejunum of 6-week-old Gata4ﬂbio/ﬂbio::
Rosa26BirA/BirA (n¼4) and Rosa26BirA/BirA (n¼4) animals were
obtained using a standard method (Driegen et al., 2005; Guo
et al., 2009; He et al., 2012). Cells ﬁxed in 1% formaldehyde for
15 min at room temperature followed by quenching in 1 M glycine
for 5 min were sonicated using a Misonix Sonicator 3000 (Misonix
Incorporated, Farmingdale, NY). Bio-ChIP was performed as pre-
viously described with the exception that magnetic beads were
washed four times with 2% SDS and twice with high salt buffer (He
and Pu, 2010). Chromatin harvested from each animal was sub-
jected to at least two independent pull-down experiments. For
each pull-down experiment, occupancy of GATA4 at the Dll1 locus
was detected by PCR using primers ﬂanking predicted GATA4
binding sites and 〈a32P-dATP. As a negative control, PCR was also
performed using primers to a region upstream of the Dll1
promoter lacking predicted GATA binding sites. Primer sequences
are listed in Supplemental Table 1. PCR products separated in 4%
polyacrylamide gels were visualized by autoradiography. Input
chromatin was diluted 1:10 prior to PCR ampliﬁcation.
Results
Loss of GATA4 and GATA6 disrupts the developing intestinal
epithelium
To test the hypothesis that GATA4 and GATA6 play redundant
roles during intestinal development, we eliminated Gata4 and
Gata6 speciﬁcally in the intestinal epithelium during embryonic
development using Villin-Cre. Among 127 three-week-old animals
genotyped, we failed to identify animals with a G4G6 dcKO
genotype (Gata4loxP/loxPGata6loxP/− Villin-Cre) demonstrating that
intestinal expression of GATA4 and GATA6 is required for survival.
We observed litters and identiﬁed a subset of pups dying within
24 h of birth. Genotyping revealed these to be G4G6 dcKO animals.
Genotyping of E18.5 embryos demonstrated the presence of
Mendelian ratios of G4G6 dcKO embryos indicating that lethality
occured during the early postnatal period.
Because G4G6 dcKOmice died within 24 h of birth, we began our
study by investigating the phenotype at E18.5. Examination of
intestines from E18.5 control (Gata4loxP/loxPGata6loxP/þ or Gata4loxP/þ
Gata6loxP/þ) and G4G6 dcKO embryos showed that mutant small
intestines were dilated compared with controls likely because
mutant tissue contained more ﬂuid compared with control tissue
(Fig. 1A). We measured the length of control and GATA4-GATA6
deﬁcient small intestine and found that mutant small intestine was
20% shorter than control small intestine (Fig. 1B). To verify GATA4
and GATA6 loss in G4G6 dcKOs, we analyzed steady-state mRNA
and protein levels by RT-PCR and immunohistochemistry. Both
GATA4 and GATA6 mRNA and protein were absent in E18.5 mutant
small intestine (Fig. 1C,D).
Because GATA4 and GATA6 are co-expressed only in the
proximal intestine (duodenum and jejunum) and our aim was to
determine the extent to which GATA4 and GATA6 function over-
laps to control small intestinal development, we performed
morphological analyses including histology, immunohistochemis-
try, and immunoﬂuorescence using tissue from the jejunum of
G4G6 dcKOs. Histological examination of the jejunum showed
defective intestinal epithelial architecture in G4G6 dcKO embryos
(Fig. 1E). Epithelial cells of villi in control tissue appeared colum-
nar with basal nuclei, whereas epithelial cells on villi in mutant
tissue appeared rounded with centrally located nuclei (Fig. 1E,
inset). Moreover, in contrast to control tissue, which contained
numerous well-developed villi, mutant tissue contained few
blunted, irregular villi (Fig. 1E). We also surveyed villus structure
in duodenal tissue of G4G6 dcKOs and found it to be similarly
abnormal in mutants (Supplemental Fig. 1). We further compared
villus structure in the jejunum between controls and mutants by
staining tissue with an antibody for the mesenchymal marker
PDGFRA to conﬁrm the presence of lamina propria mesenchyme
underlying villus epithelium and found comparable expression
and localization of PDGFRAþ mesenchyme between controls and
mutants (Fig. 1F). Moreover, although villi of mutants were
abnormal in shape and number, clusters of PDGFRAþ cells were
present at remaining villus tips; such clusters are required for
villus morphogenesis (Karlsson et al., 2000; Walton et al., 2012).
Abnormal villus architecture suggested the possibility that
epithelial cells were decreased in mutants compared with con-
trols. We stained tissue for the epithelial cell-speciﬁc nuclear
marker HNF4A and counted HNF4Aþ cells per section; we found
no difference in the average number of epithelial cells present in
mutant tissue compared with control tissue (Fig. 1G). HNF4A
staining further revealed that mutant epithelial cells within inter-
villus regions were densely packed containing thin, elongated
nuclei reminiscent of the pseudostratiﬁed epithelium present
during early intestinal development (Fig. 1G, inset).
Because previous studies of GATA4 and GATA6 in the intestine
demonstrated that overall intestinal cell fate is normally speciﬁed
and maintained in several different models of intestinal GATA4
and/or GATA6 knockout (Bosse et al., 2006; Battle et al., 2008;
Beuling et al., 2011), we did not expect to ﬁnd that elimination of
both GATA4 and GATA6 during development would alter general
intestinal epithelial cell fate. Moreover, Villin-Cre is not active in
the intestine at the time of intestinal speciﬁcation. Therefore, to
conﬁrm that general intestinal epithelial cell identity was intact in
GATA4-GATA6 deﬁcient small intestine, we analyzed the steady-
state mRNA and protein levels of CDX2, one of the earliest markers
of intestinal fate, by qRT-PCR and immunohistochemistry. We
found no decrease in CDX2 in mutants compared with controls
(Fig. 1H). In fact, although RNA levels were unchanged, CDX2
protein staining was more intense in mutants compared with
controls (Fig. 1H).
Loss of GATA4 and GATA6 in the small intestinal epithelium alters
epithelial cell populations at E18.5
GATA4 and GATA6 function as transcription factors suggesting
that the observed defects reﬂect changes in the intestinal gene
expression proﬁle in their absence. To understand mechanisms of
GATA function in the intestine, we performed Affymetrix oligonu-
cleotide array analysis to compare gene expression proﬁles
between the intestinal epithelium of control and G4G6 dcKO
E18.5 embryos. We identiﬁed 367 genes with expression increased
Z2.0 fold (Pr0.05) and 403 genes with expression decreased
Z2.0 fold (Pr0.05) (Supplemental Table 3). We used Ingenuity
Pathway Analysis (IPA) software to categorize genes with altered
expression in mutants and found lipid metabolism, small molecule
biochemistry, molecular transport, carbohydrate metabolism, and
vitamin and mineral metabolism as the top ﬁve biological func-
tions affected (Supplemental Fig. 2). These data suggested a defect
in the enterocyte population in GATA4-GATA6 deﬁcient intestine.
Consistent with an enterocyte defect, we identiﬁed multiple
important enterocyte-speciﬁc transcripts as decreased in mutant
tissue (Table 1). We performed qRT-PCR to compare levels of these
transcripts between control and mutant epithelium and conﬁrmed
these as signiﬁcantly decreased in mutants (Fig. 2A). Moreover, we
observed decreased alkaline phosphatase positive (APþ) cells in
GATA4-GATA6 mutants compared with controls, and any APþ
cells present in mutant tissue stained less intensely compared
with control tissue (Fig. 2B). Finally, using gene array data, we
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further identiﬁed an increase in abundance of distal intestinal
marker transcripts in mutants compared with controls (Table 1).
We assayed the expression of these targets by qRT-PCR (Fig. 2C)
and observed signiﬁcant increases in these transcripts in mutant
epithelium. Together, these data suggest that mutant epithelium
contained fewer enterocytes and that any remaining enterocytes
expressed genes characteristic of more distal enterocytes and
colonocytes rather than proximal enterocytes.
Gene array data further indicated changes in the other intest-
inal epithelial cell populations present at E18.5 including enter-
oendocrine cells, goblet cells and proliferative cells. We found
expression of transcripts encoding several markers of mature
Fig. 1. Loss of GATA4 and GATA6 disrupts intestinal epithelial architecture at E18.5. (A) Intestine from G4G6 dcKO embryos appeared dilated and translucent compared with
controls. (B) Average small intestine length was decreased in G4G6 dcKO embryos (n¼29) compared with controls (n¼29). (C) RT-PCR demonstrated efﬁcient Gata4-Gata6
knockout in intestinal epithelial cells of G4G6 dcKO embryos. Gapdh was used as loading control. (D) GATA4 and GATA6 immunohistochemistry showed an absence of
nuclear staining (brown) in jejunum of mutants compared with controls. (E) H&E staining of jejunal tissue demonstrated villus loss and altered cell shape in the absence of
GATA4-GATA6. Inset shows higher magniﬁcation of starred region. (F) PDGFRA immunohistochemistry showed comparable levels and localization between control and
mutant intestine. Right panels show higher magniﬁcation of starred regions. (G) HNF4A staining showed that mutant jejunal tissue contained densely packed nuclei within
the intervillus regions. Inset shows higher magniﬁcation of starred region. Epithelial cell number was not changed between control (average 1646 HNF4Aþ cells/section) and
G4G6 dcKO (average 1520 HNF4Aþ cells/section) embryos (n¼Z3 sections from 3 control and 3 mutant intestines). (H) Intestinal fate was preserved in intestine of G4G6
dcKOs. Expression of CDX2, an early marker of intestinal fate, was assayed by qRT-PCR (left) and immunohistochemistry (right). Both Cdx2 mRNA and CDX2 protein were
comparable between controls and mutants. All scale bars¼50 μm. Error bars show standard error of the mean (SEM). P-value was determined by two-sample Student t test:
nnPr0.01.
E.M. Walker et al. / Developmental Biology 392 (2014) 283–294286
Fig. 2. Enterocyte and enteroendocrine cells are negatively affected by loss of GATA4 and GATA6 at E18.5. (A) qRT-PCR analysis of intestinal epithelial cells from control and G4G6 dcKO
embryos conﬁrmed that the abundance of transcripts encoding jejunal enterocyte-speciﬁc markers was signiﬁcantly decreased in mutants compared with controls. (B) Alkaline
phosphatase activity was decreased in mutant jejunum compared with control tissue. Scale bars¼50 μm (C) qRT-PCR analysis of intestinal epithelial cells from control and G4G6 dcKO
embryos conﬁrmed that the abundance of transcripts encoding distal enterocyte-speciﬁc markers was signiﬁcantly increased in mutants compared with controls. (D) qRT-PCR analysis
of intestinal epithelial cells from control and G4G6 dcKO embryos conﬁrmed changes in enteroendocrine marker expression in mutants compared with controls. Ngn3was unchanged.
(E) Chromogranin Aþ cells (arrows) were detected in jejunal tissue from control and G4G6 dCKO embryos showing the presence of enteroendocrine cells in both tissues. Scale
bars¼50 μm (F) qRT-PCR analysis of intestinal epithelial cells from control and G4G6 dcKO embryos conﬁrmed that the abundance of transcripts encoding proliferative cell markers
was signiﬁcantly increased in mutants compared with controls. (G) Immunohistochemistry for proliferation markers CD44 (brown membrane stain) and SOX9 (brown nuclear stain)
showed increased levels of both in jejunum of mutants. Scale bars, 10 micrographs¼100 μm; 20 micrographs¼50 μm. (H) EdU incorporation showed an increase in proliferating
cells within the jejunal epithelium of mutants. Co-staining for EdU (red) and laminin (LAM, green) differentiated between proliferating epithelial cells (EdUþ , LAM-) and proliferating
mesenchymal cells (EdUþ , LAMþ). DAPI (blue) identiﬁed nuclei. Scale bars¼50 μm (I) The proportion of proliferating cells within the jejunal epitheliumwas determined by dividing
the number of EdUþDAPIþLAM- cells by the number of DAPIþLAM- cells (n¼10 ﬁelds per embryo, 3 control and 3 mutant embryos). Error bars show SEM. P-value was determined
by two-sample Student t test: nnPo0.01. For all qRT-PCR, cells from 3 control and 3 mutant intestines were assayed at least 3 times. Gapdhwas used for normalization. Error bars show
SEM. P-value was determined by two-sample Student t test: nPr0.05, nnPr0.01.
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enteroendocrine cells to be lower in mutant epithelium compared
with controls including ChgA, Cck, and Gip (Table 1). ChgA is a pan-
enteroendocrine cell product whereas Cck and Gip mark speciﬁc
subpopulations of enteroendocrine cells located primarily in the
proximal intestine (Schonhoff et al., 2004). qRT-PCR conﬁrmed
these gene products as less abundant in mutants compared with
controls (Fig. 2D). We used qRT-PCR to examine expression of
Peptide YY (Pyy), which marks a population of enteroendocrine
cells primarily localize to the distal intestine (Schonhoff et al.,
2004). We found Pyy to be decreased in mutants compared with
controls (Fig. 2D). Despite decreased expression of differentiated
enteroendocrine cell markers, Ngn3, the transcription factor
required for enteroendocrine cell speciﬁcation, was unchanged
(Fig. 2D). Although qRT-PCR showed a signiﬁcant decrease in ChgA,
mutant intestine maintained CHGAþ cells (Fig. 2E). These cells
stained with an intensity equivalent to those in control tissue
suggesting that ChgA and other enteroendocrine-speciﬁc tran-
script levels were lower because there were fewer fully differ-
entiated enteroendocrine cells in mutant tissue compared with
controls.
Several transcripts involved in proliferation were identiﬁed by
IPA as increased in GATA4-GATA6 mutants compared with controls
(Table 1), and qRT-PCR conﬁrmed these as signiﬁcantly increased
in mutants (Fig. 2F). Immunohistochemical staining for CD44 and
SOX9, which mark the proliferative intervillus region of the small
intestine (Spence et al., 2011), suggested that mutant epithelium
contained increased proliferative cells compared with controls
(Fig. 2G). Therefore, to quantitate proliferation, we measured
EdU incorporation after a 3 h pulse. We stained tissue for EdU
incorporation (proliferative cells), laminin (a mesenchyme marker
used to discriminate between proliferating cells within the epithe-
lium and mesenchyme) and DAPI (Fig. 2H) and determined the
proportion of proliferating cells in the small intestinal epithelium
of controls and mutants. We observed 16% of cells in control
epithelium as proliferating whereas 28% of cells in mutant epithe-
lium were detected as proliferating (Fig. 2I).
Finally, gene array data showed that transcripts encoding
goblet cell markers were increased in mutants compared with
controls (Table 1); qRT-PCR conﬁrmed increased abundance of
these transcripts in mutant tissue (Fig. 3A). Examination of tissue
stained with Alcian Blue (AB) or an antibody recognizing MUCIN
2 conﬁrmed an increase in goblet cells in mutant tissue compared
with control tissue (Fig. 3B). To compare the number of goblet cells
between control and mutant tissue, we counted ABþ cells and
found a signiﬁcant increase in mutants compared with controls.
Control tissue contained an average of 59 ABþ cells per section
whereas mutant tissue contained an average of 253 ABþ cells
per section (Fig. 3C). As described above, the total number of
epithelial cells present in mutant tissue was comparable with
control tissue (Fig. 1G). Therefore, we concluded that there is a 4-
fold increase in the number of goblet cells in GATA4-GATA6
deﬁcient intestine.
Goblet cells are increased in intestine of Gata4Gata6 dcKO E16.5
embryos
Because the Villin promoter used to drive Cre activity becomes
active in the intestinal epithelium as early as E12.5 (Madison et al.,
2002), it is possible that the phenotype observed at E18.5
represents both primary and secondary effects of GATA4-GATA6
loss. Therefore, we used RT-PCR to determine the earliest stage at
which both Gata4 and Gata6 were efﬁciently removed from the
intestine and assessed the phenotype at that stage. Although Gata6
mRNA was decreased or absent in mutant intestine by E15.5, we
did not detect decreases in Gata4 mRNA until E16.5 (Fig. 4A).
Therefore, we examined intestinal morphology, cell lineage alloca-
tion, and proliferation in intestines of G4G6 dcKO embryos at
E16.5, the ﬁrst time at which we detected robust changes in both
Gata4 and Gata6 levels.
Comparison of H&E stained tissue from control and mutant
embryos between E16.5-E18.5 revealed that intestinal architecture
defects developed over time concurrent with loss of Gata4 and
Gata6 expression. At E16.5, when both Gata4 and Gata6 were ﬁrst
reduced, mutant intestine appeared indistinguishable from control
intestine; by E18.5, intestinal epithelial structure was severely
disrupted in mutant intestine compared with control intestine
(Compare Figs. 1E, 4B). At E17.5, we detected morphological changes
intermediate to those at E16.5 and E18.5 (data not shown). Despite
normal intestinal epithelial morphology at E16.5, we detected
changes in enterocyte, goblet cell, and proliferative cell marker
expression; enteroendocrine cell marker expression was similar
between controls and mutants. qRT-PCR showed decreased abun-
dance of enterocyte markers and increased abundance of goblet and
proliferative cell markers at E16.5 (Fig. 4C). Although enterocyte
marker transcripts were decreased and proliferative marker tran-
scripts were increased, staining for AP activity and SOX9 appeared
Table 1
Genes encoding transcripts related to epithelial cytodifferentiation and proliferation identiﬁed by Affymetrix gene array analysis with increased or decreased expression
(Z2.0-fold, Pr0.05) in E18.5 GATA4-GATA6 deﬁcient intestinal epithelium compared with control epithelium.
Gene Fold Change1 Gene Fold Change1
Enterocyte Markers Enteroendocrine Cell Markers
ATP-binding cassette family member 5 (Abcg5) 8.1 Cholecystokinin (Cck) 2.3
ATP-binding cassette family member 8 (Abcg8) 9.0 Chromogranin A (ChgA) 2.1
Apolipoprotein A4 (Apoa4) 6.0 Gastric inhibitory peptide (Gip) 3.8
Apolipoprotein C2 (Apoc2) 3.8 Goblet Cell Markers
Apolipoprotein C3 (Apoc3) 2.0 Atonal homolog 1 (Atoh1) 2.3
Fatty acid binding protein 1 (Fabp1) 3.9 SAM pointed domain containing ets transcription factor (Spdef) 2.6
Fatty acid binding protein 2 (Fabp2) 6.6 Mucin 1 (Muc1) 2.6
Lactase (Lct) 23.4 Mucin 2 (Muc2) 2.4
Solute carrier family 2 member 2 (Slc2a2) 2.5 Proliferative Cell Markers
Solute carrier family 2 member 5 (Slc2a5) 3.10 Cyclin D1 (Ccnd1) 2.4
Solute carrier family 5 member 11 (Slc5a11) 3.3 CD44 antigen (Cd44) 4.1
Distal Intestine Markers Cyclin-dependent kinase 6 (Cdk6) 3.1
Carbonic anhydrase 1 (Car1) 10.9 Leucine rich repeat containing G protein coupled receptor 5 (Lgr5) 2.6
Claudin 8 (Cldn8) 6.2 SRY-box containing gene 9 (Sox9) 2.2
Fatty acid binding protein 6, ileal (Fabp6) 32.7
Fibroblast growth factor 15 (Fgf15) 8.40
Solute carrier family 10, member 2 (Slc10a2) 17.3
1 Pr0.05
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similar between controls and mutants (Fig. 4B). We further quanti-
ﬁed proliferation using EdU incorporation as described above and
found no increase in the proportion of proliferative cells within the
epithelium of E16.5 G4G6 dcKO intestine compared with controls
(Fig. 4D,E). Goblet cell number, however, was increased in E16.5
GATA4-GATA6 deﬁcient intestinal epithelium compared with con-
trols (Fig. 4B,F). Counting ABþ cells showed that control tissue
contained an average of 12 goblet cells per section whereas mutant
tissue contained an average of 28 goblet cells per section represent-
ing a greater than two-fold increase in goblet cells in E16.5 GATA4-
GATA6 deﬁcient intestine (Fig. 4F). Counting of HNF4Aþ cells
per section demonstrated there was no change in epithelial cell
number (Fig. 4F).
The Dll1 gene contains GATA binding sites that are occupied by GATA4
in the mouse small intestinal epithelium
Previous analysis of GATA4 expression in the intestinal epithe-
lium shows it to be absent in goblet cells (Bosse et al., 2006).
Although Beuling et al. (2011) report goblet cells as GATA6
positive, we found that MUC2þ cells lacked GATA6 nuclear
staining when a GATA6-speciﬁc antibody was used (Supplemental
Figs. 3A,4). We attribute this discrepancy between results to the
H-92 GATA6 antibody used by Beuling et al., which we demon-
strated to detect a non-speciﬁc antigen in Gata6 knockout small
intestine (Supplemental Fig. 4). Because both GATA4 and GATA6
are absent from mature goblet cells and the observed increase in
goblet cells corresponded with the onset of GATA4-GATA6
depletion, we hypothesized that GATA factors function in the
progenitor cell population to inhibit goblet cell differentiation in
the developing intestine. Importantly, both GATA4 and GATA6
are expressed in the proliferative progenitor population in the
small intestinal epithelium ((Supplemental Fig. 3B) and (Bosse
et al., 2006)). As Notch signaling plays a critical role in determining
secretory versus absorptive cell differentiation, we examined gene
array data for evidence of altered Notch signaling. Speciﬁcally, as
decreased Notch activity would favor secretory lineage differentia-
tion, we focused on changes in gene expression predicted to
decrease Notch signaling and found that expression of the Notch
ligand Dll1 was reduced in mutants (Supplemental Table 3). qRT-
PCR conﬁrmed decreased Dll1 abundance in mutants (Fig. 5A).
Similar to G4G6 dcKOs, goblet cells are increased in mice lacking
DLL1 in the small intestine (Pellegrinet et al., 2011; Stamataki et
al., 2011). Loss of GATA6 in the ileum of adult mice also results in
decreased Dll1 expression and increased goblet cell number in the
mature ileum (Beuling et al., 2011). Therefore, to assess Notch
signaling activity in GATA4-GATA6 mutants, we examined expres-
sion of the Notch target gene Olfm4 in control and mutant tissue.
Olfm4 was chosen in light of recent work demonstrating that it
serves as a sensitive indicator of Notch signaling in the intestine
(VanDussen et al., 2012). qRT-PCR showed that Olfm4 expression
was signiﬁcantly decreased in mutant tissue compared with
control tissue (8.7 fold, Pr0.05) (Fig. 5A) suggesting that Notch
signaling was indeed altered in the intestine of G4G6 dcKOs.
Using MatInspector software, we queried a region of the Dll1
gene including 1000 bp upstream of the Dll1 transcriptional start
Fig. 3. Goblet cells are increased in GATA4-GATA6 deﬁcient intestine at E18.5. (A) qRT-PCR analysis of intestinal epithelial cells from control (n¼3) and G4G6 dcKO (n¼3)
embryos conﬁrmed that the abundance of transcripts encoding goblet cell markers was signiﬁcantly increased in mutants compared with controls. Assays were performed at
least 3 times. Gapdh was used for normalization. Error bars show SEM. P-value was determined by two-sample Student t test: nPr0.05, nnPr0.01. (B) Alcian Blue (AB)
staining and MUCIN 2 immunohistochemistry (brown) identiﬁed goblet cells in control and G4G6 dcKO jejunum. Scale bars¼50 μm. (C) Quantitation of ABþ cells
demonstrated a signiﬁcant increase in goblet cells in GATA4-GATA6 deﬁcient intestinal epithelium compared with controls (n¼Z3 sections from 3 control and 3 mutant
intestines). Error bars show SEM. P-value was determined by two-sample Student t test: nnPo0.01.
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Fig. 4. Epithelial cell populations are altered in GATA4-GATA6 deﬁcient intestine at E16.5. (A) Gata4 and Gata6 knockout in small intestine between E15.5-E17.5 was assessed using RT-
PCR. Gapdh was used as loading control. At E15.5, although Gata6 levels were decreased in mutant intestine, Gata4 levels remained high. At E16.5, Gata4 transcript was decreased
although levels varied between embryos. At E17.5, Gata4 was virtually absent in mutants. Gapdh was used as loading control. (B) H&E, alkaline phosphatase activity, and SOX9
immunohistochemistry were comparable between jejunum from control and G4G6 dcKO embryos at E16.5. Alcian Blue (AB) staining demonstrated increased goblet cells at E16.5.
(C) qRT-PCR analysis of intestinal epithelial cells from control (n¼3) and G4G6 dcKO (n¼3) E16.5 embryos demonstrated that abundance of enterocyte markers was decreased and that
abundance of proliferation markers and goblet cell markers was increased in mutants compared with controls. Assays were performed at least 3 times. Gapdh was used for
normalization. Error bars show SEM. P-value was determined by two-sample Student t test: nPr0.05, nnPr0.01. (D,E) The number of proliferative cells present in control and mutant
jejunal epithelium, determined by EdU incorporation as described in Fig. 4C, D, was unchanged between controls and G4G6 dcKO intestine at E16.5 (n¼Z5 ﬁelds per embryo,
4 control and 4 mutant embryos). (F) Quantitation of ABþ cells demonstrated a signiﬁcant increase in goblet cells in GATA4-GATA6 deﬁcient jejunal epithelium compared with
controls (n¼Z3 sections from 3 control and 3mutant intestines). Epithelial cell number, determined by HNF4Aþ nuclei, was unchanged (Average 902 HNF4Aþ cells/section controls;
average 906 HNF4Aþ cells/section mutants). All scale bars¼50 μm. Error bars show SEM. P-value was determined by two-sample Student t test: nPr0.05, nnPr0.01.
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site and the ﬁrst exon of Dll1 for GATA binding sites. Because GATA
binding sites occur quite frequently in the genome, we limited our
investigation to this 1637 bp region to capture the core promoter
and potential regulatory sites located within the DNA encoding the
5'UTR. GATA factors, including GATA4 and GATA6, have been
shown to bind to consensus binding sites within 5'UTRs in other
genes to regulate gene expression (Wang et al., 2000; de Vooght
et al., 2008; LaVoie et al., 2010). Within this sequence, MatInspector
identiﬁed three GATA binding sites all residing within a region of
Dll1 exon 1 encoding the 5'UTR (Fig. 5B). Although each sequence
represents a GATA binding consensus sequence, only GATABS3
conforms to the rigorous GATA consensus sequence WGATAR.
Moreover, this site was speciﬁcally annotated as a putative GATA4
binding site (V$GATA4.01) whereas the other two were annotated
as putative GATA1 binding sites (V$GATA1.06).
To determine if GATA factors occupy these sites in vivo in the
intestinal epithelium, we performed biotin-mediated chromatin
immunoprecipitation (bioChIP) using Gata4ﬂbio/ﬂbio::Rosa26BirA/BirA
mice (Driegen et al., 2005; He et al., 2012). We chose this approach
because of lack of GATA4 antibodies suitable for ChIP in the
intestinal epithelium. We were limited to analyzing GATA4
because of lack of a suitable GATA6 ChIP antibody and lack of a
biotin-modiﬁed mouse line. The Gata4ﬂbio/ﬂbio::Rosa26BirA/BirA
mouse line used is engineered such that endogenous GATA4
protein is biotinylated at its C-terminus. Streptavidin beads were
used to precipitate biotinylated GATA4-chromatin complexes, and
PCR was used to detect GATA4 occupancy at its predicted binding
sites within Dll1. Four Gata4ﬂbio/ﬂbio::Rosa26BirA/BirA and four
Rosa26BirA/BirA mice were used to determine GATA4 occupancy,
and chromatin isolated from each animal was assayed in at least
two independent bio-ChIP experiments. We found GATA4 to be
enriched at its binding sites in Dll1 in chromatin from Gata4ﬂbio/
ﬂbio::Rosa26BirA/BirA mice compared with control samples from
Rosa26BirA/BirA mice (Fig. 5C; data shown represent a total of nine
independent PCR assays of GATA4 occupancy performed with
chromatin from multiple bio-ChIP experiments). Therefore, we
conclude that GATA4 occupies chromatin within the Dll1 gene. It is
important to note that although we can conclude that GATA4
occupies Dll1, we cannot distinguish between its occupancy of
speciﬁc predicted binding site(s) because of their proximity to one
another; only 226 bp separate GATABS1/2 and GATABS3. Taken
together, our observations that Dll1 and Olfm4 were reduced in
mutants and that GATA4 was bound to putative transcriptional
regulatory elements of Dll1 imply that GATAs regulate Notch
activity in the small intestinal epithelium to control cytodiffe-
rentiation.
Discussion
Our data demonstrate that GATA4 and GATA6 play a redundant
yet essential role in regulating cytodifferentation during small
intestinal epithelial development. Enterocytes and enteroendo-
crine cell populations were compromised, whereas goblet cell and
proliferative cell populations were enhanced. Because we
observed no change in total epithelial cell number in mutants
compared with controls, we conclude that alterations in abun-
dance of speciﬁc epithelial cell types in mutants reﬂect changes in
differentiation of progenitors to these lineages in the absence of
GATA4 and GATA6.
One striking change in cytodifferentiation observed was
increased goblet cell number. In fact, this phenotype was observed
as early as E16.5, the ﬁrst time at which both Gata4 and Gata6
levels were reduced. Because GATA4 and GATA6 are absent from
mature goblet cells but expressed in the the intestinal epithelial
progenitor cell population, we conclude that GATA factors function
in progenitor cells to regulate cell fate decisions. We hypothesized
that GATAs inhibit secretory cell differentiation in the developing
small intestine by modulating Notch signaling through transcrip-
tional regulation of the Notch ligand Dll1. Like G4G6 dcKO mice,
goblet cells are signiﬁcantly increased in mice lacking DLL1 in the
small intestine (Pellegrinet et al., 2011; Stamataki et al., 2011).
Fig. 5. GATA4 occupies binding sites in the Dll1 gene. (A) qRT-PCR analysis of
intestinal epithelial cells from control and G4G6 dcKO E18.5 embryos demonstrated
decreased levels of Dll1 and Olfm4 transcripts in mutants compared with controls.
Cells from 3 control and 3 mutant intestines were assayed at least 3 times. Gapdh
was used for normalization. Error bars show SEM. P-value was determined by two-
sample Student t test: nnPr0.01. (B) Illustration of Dll1 gene depicting three GATA
binding sites (GATABS1/2, GATABS3) predicted by MatInspector software. All three
sites reside within a region of exon 1 that encodes the Dll1 5'UTR. The core GATA
sequence is indicated by italics. Arrows denote bio-ChIP primers. E1, exon 1; US,
upstream primer pair spanning a region without a predicted GATA binding site
(31,199 to 31,357 bp; bio-ChIP negative control). (C) PCR demonstrated GATA4
enrichment at predicted binding sites GATABS1/2 and GATABS3 in chromatin from
two GATA4FlagBio/BirA animals compared with chromatin from two control GATA4
wild-type/BirA animals. No enrichment was evident using US primers. Input shows
that equivalent chromatin amounts were used in each bio-ChIP assay. Four
GATA4FlagBio/BirA and four BirA mice were used to generate bio-ChIP data.
Chromatin isolated from each animal was assayed in least two independent bio-
ChIP experiments. PCR data shown in this panel are representative of nine PCR
assays of GATA4 occupancy at these sites.
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Futher supporting our proposal that GATA4-GATA6 loss dampens
Notch signaling in the developing intestine, we found expression
of Olfm4, a sensitive readout of Notch signaling in the intestine, to
be signiﬁcantly reduced in mutant tissue compared with controls.
Although we examined expression of other downstream Notch
targets including Hes1 and Hes6, we found levels of these to be
unchanged between controls and mutants (data not shown).
Notch signaling in the intestine, however, is complex, and its
precise functions in embryonic intestine during development are
less clear than its role in the mature intestinal epithelium. More-
over, even when DLL1 is completely absent from the intestinal
epithelium in a conditional knockout model, Hes1 levels decrease
by only 44%, and Hes5 levels remain constant (Stamataki et al.,
2011). Increased expression of Dll4 in DLL1 deﬁcient intestine may
partially explain this result (Stamataki et al., 2011). Similarly, our
gene array analysis of GATA4-GATA6 deﬁcient intestine identiﬁed
a 2.5 fold increase in Dll4 mRNA in mutants compared with
controls (Supplemental Table 3). Olfm4 expression was not exam-
ined in the intestine of Dll1 cKOs.
Further supporting our hypothesis that GATAs inhibit secretory
cell differentiation by regulating Notch through DLL1 is our ﬁnding
of GATA4 enrichment at predicted GATA bindings sites within the
Dll1 gene. Such data suggest that GATA4 directly regulates Dll1
transcription in the developing intestine. Because of the proximity
between the three predicted GATA binding sites and the nature of
ChIP experiments, we can conclude that GATA4 occupies Dll1, but
we cannot distinguish which site(s) among these is responsible. The
facts that GATABS3 is predicted as a GATA4 binding site and that
this site conforms to the WGATAR consensus sequence suggest it as
the best candidate among the three for GATA4 binding. Because we
limited our screen for GATA binding sites to 1000 bp upstream of
the Dll1 transcriptional start site and exon 1, it is possible that
additional GATA binding sites residing outside this region also
contribute to Dll1 transcriptional regulation. Nevertheless, we have
deﬁnitively shown using ChIP that GATA4 occupies chromatin
within the Dll1 locus. Although we were unable to test GATA6
occupancy at these sites because of a lack of suitable ChIP
antibodies, we propose that GATA6 functions similarly. Supporting
this proposal, we found small increases in goblet cells in both Gata4
cKO (þ1.6-fold) and Gata6 cKO (þ1.7-fold) embryos at E18.5
(Supplemental Fig. 5). When both factors were simultaneously
deleted, however, goblet cells quadrupled suggesting an additive
effect between these factors in Dll1 regulation.
Beuling et al. (2011) had previously proposed that GATA4 and/
or GATA6 regulate secretory cell differentiation downstream of
Notch signaling through repression of Spdef, a transcription factor
regulating goblet cell maturation. However, a recent study by the
same group demonstrates that increased SPDEF in the absence of
GATA6 does not drive changes in secretory cell lineage allocation
as concurrent loss of Spdef with Gata6 does not rescue the Gata6
cKO ileal secretory cell phenotype (Aronson et al., 2014). In this
manuscript, we provide an alternative mechanism to explain how
GATA factors inﬂuence intestinal epithelial cell fate. The experi-
mental evidence we present supports a novel mechanism through
which GATAs affect intestinal epithelial cytodifferentiation by
directly regulating Notch signaling itself through transcriptional
control of the Notch ligand Dll1 during embryonic development of
the intestine.
Loss of GATA4-GATA6 in the developing intestine also caused a
reduction in enterocyte number and a change in enterocyte
identity evidenced by decreased AP activity in mutant tissue and
abnormal expression of transcripts encoding genes characteristic
of distal enterocytes and colonocytes in mutant epithelium.
Changes in cellular identity agree with previous analyses of Gata4
and Gata6 cKO animals. Gata4 cKO animals exhibit a dramatic
conversion of jejunal enterocytes toward an ileal fate; Gata6 cKO
animals exhibit increased colonic marker expression in the
ileum (Battle et al., 2008; Beuling et al., 2011). Because GATA4
and GATA6 are expressed in enterocytes and changes in enterocyte
gene expression coincided with GATA4-GATA6 elimination at
E16.5, we conclude that the enterocyte phenotype is a primary
effect of GATA4-GATA6 deletion and that both are required for
enterocyte differentiation. Moreover, we conclude that GATA4 and
GATA6 are required for proper intestinal architecture. In the
absence of GATA4 and GATA6, abnormal enterocyte function
causes increased lumenal ﬂuid accumulation and gut dilation.
These mechanical changes occuring in mutants likely explain
alterations in villus shape and number. Taken together, abnormal
villus structure, decreased enterocyte number, and deviations
from the proper jejunal expression proﬁle in remaining entero-
cytes likely cause malnutrition in mutant neonates leading
to death.
Because enteroendocrine cells constitute only 1% of the intest-
inal epithelium, we did not directly quantitate their abundance but
instead used qRT-PCR to examine expression of key enteroendo-
crine cell markers. At E18.5, we observed reduced levels of multi-
ple mature enteroendocrine cell markers. Therefore, we conclude
that loss of GATA4 and GATA6 in the developing small intestinal
epithelium impairs enteroendocrine cell differentiation. Changes
in expression of mature enteroendocrine cell markers also occur in
single Gata4 and Gata6 Villin-Cre cKO mice and in mice with
deletion of both Gata4 and Gata6 in adult intestine (Bosse et al.,
2006; Battle et al., 2008; Beuling et al., 2011). Furthermore, Ngn3
levels are decreased in ileum of adult Gata6 cKO mice and in
duodenum and jejunum of mice with deletion of both Gata4 and
Gata6 in adult intestine leading to the conclusion that GATA factors
are required for enteroendocrine lineage commitment (Bosse et
al., 2006; Beuling et al., 2011). In contrast, we found no difference
in Ngn3 expression between controls and GATA4-GATA6 mutants
at E18.5 implying that GATAs function differently during develop-
ment affecting enteroendocrine cell differentiation rather than
committment to enteroendocrine cell fate. Moreover, we found no
change in enteroendocrine cell marker expression at E16.5 sug-
gesting that changes in enteroendocrine cell populations represent
a secondary consequence of GATA4-GATA6 loss. As GATA factors
regulate intestinal enterocyte identity, it is possible that GATAs
indirectly affect enteroendocrine cells downstream of regional
identity regulation.
It is unclear why with greater proliferation in mutants com-
pared with controls, we failed to observe an increase in epithelial
cell number. We examined cell death in mutants by staining for
active caspase 3 (data not shown) and found no change demon-
strating that this phenomenon cannot be explained by a conco-
mitant cell loss. In contrast to elimination of GATA4 and GATA6 in
the developing intestine, elimination of GATA factors in the adult
small intestine or the pancreas inhibits proliferation (Beuling et al.,
2011; Carrasco et al., 2012; Xuan et al., 2012). It is possible that the
enterocyte differentiation blockade in GATA4-GATA6 mutants
caused proliferating progenitors to accumulate. Although we
observed changes in proliferation marker expression at E16.5,
arguing a primary role for GATAs in controlling proliferation, it is
also possible that increased proliferation simply reﬂects a com-
pensatory response to severe disruption to the enterocyte popula-
tion and villus architecture. Similar changes are observed in other
intestinal mutants in which enterocytes and villus structure are
perturbed (Hermiston and Gordon, 1995; Bondow et al., 2012).
Finally, our ﬁnding that proliferation is increaed in the context of
decreased DLL1-driven Notch signaling highlights the complexity
of the Notch pathway in the developing intestinal epithelium. It is
likely that individual Notch ligands in combination with cognate
Notch receptors regulate distinct signaling outcomes such as
proliferation or cytodifferentiation.
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Conclusions
Based on our data, we propose that GATA4 and GATA6 repress
goblet cell differentiation through transcriptional regulation of the
Notch ligand Dll1 during epithelial cell lineage speciﬁcation
(Fig. 6). Recently, the Clevers group demonstrated that cells
expressing high levels of Dll1 exist within the progenitor popula-
tion present in epithelium of the adult small intestine, and it is
this population that constitutes the secretory progenitor pool
(van Es et al., 2012). Such cells provide the Notch ligand DLL1 to
adjacent neighboring progenitors to drive Notch signaling within
these neighbors thereby promoting differentiation of these cells to
the enterocyte fate. We propose that GATA4 and GATA6 function to
enhance Dll1 expression within the secretory progenitor pool.
When these factors are lost, Dll1 expression is reduced; concomi-
tantly, the total amount of Notch ligand available to secretory
progenitor cell neighbors is reduced. This reduction in Notch
signaling thereby skews the balance between enterocytes and
secretory cells resulting in a loss of enterocytes and a gain in
goblet cells. Finally, as GATA4 and GATA6 are absent in mature
goblet cells, we propose that signals within differentiating goblet
cells subsequently repress GATA4 and GATA6 expression during
cell maturation. The ﬁnding that DLL1 levels are lower in
differentiated goblet cells supports the hypothesis that GATA
levels drop as progenitor cells differentiate and mature along the
goblet cell lineage (Stamataki et al., 2011).
In conclusion, this study expands our understanding of the
signaling pathways and transcription factors required for absorp-
tive and secretory cell differentiation during intestinal develop-
ment. We demonstrate that both GATA4 and GATA6 play an
essential role in deﬁning epithelial architecture and in controlling
cytodifferentiation in the small intestine. Moreover, our data
highlight a novel role for GATA factors in ﬁne tuning Notch
signaling in the intestine through transcriptional control of the
Notch ligand Dll1 to repress goblet cell differentiation thereby
promoting enterocyte differentiation.
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